GLP-1 Graduation: Supporting Population Health During and After
Download the full guide and learn how Signos enables organizations to improve population metabolic health and support long-term goals while on a GLP-1 and as they graduate off.
of Members report seeing progress within the first month.*
What Is Signos?
Signos, Inc. is committed to building technology that drives better health outcomes. Using a mobile AI-driven system and a continuous glucose monitor (CGM), Signos offers personalized insights into how food, movement, sleep, stress, and more affect each unique body and giving in-the-moment habit change.
With over 73% of Americans overweight or obese and 88% metabolically unhealthy, Signos offers a science-backed path to sustainable weight management through the lens of individual metabolism.
$1,861 Per Year
Companies spend $1,861 more per obese employee per year in medical costs. Supporting health isn't just good for your team; it's good for your bottom line.
Signos uses hundreds of millions of data points to build a unique metabolic profile for each member. By monitoring glucose, the body's primary fuel source, the app guides users to make real-time adjustments to manage weight and build habits that support sustainable weight once goals are met.
I have to say this is a great eye opener. I have been borderline diabetic for 20 years with never any assistance from doctors. Thanks to this program. I have so much more insight on what I can and can't eat without spiking. Love it...love it ....love it ......I can't say anything better about it.
- Cheryl R.
I have had other CGMs, and I really love the real world guidance I am receiving from Signos. I love the in-app support, the podcasts, and help in understanding the numbers, and how to change my habits. Thanks! I am so happy to be on this journey!
- Briana D.
Signos is helping me lower my glucose numbers and stay off of diabetes medications. The insight into exactly what spikes my glucose and how much exercise I need in order to see improvement has been very valuable.
- Peggy W.
Get the Guide
Ready to learn how Signos can help your organization?
We respect your privacy and protect your data. Review our Privacy Policy—you can unsubscribe at any time.
* Data based on member reported weight changes towards goals within the first month. Data on file. Signos.
SIGNOS INDICATIONS: The Signos Glucose Monitoring System is an over-the-counter (OTC) mobile device application that receives data from an integrated Continuous Glucose Monitor (iCGM) sensor and is intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Signos Glucose Monitoring System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Signos Glucose Monitoring System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursions. This information may be useful in helping users to maintain a healthy weight.
The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
See user guide for important warnings and precautions.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
STELO INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
